BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 9250146)

  • 1. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
    Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
    Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).
    Tejpar S; Nollet F; Li C; Wunder JS; Michils G; dal Cin P; Van Cutsem E; Bapat B; van Roy F; Cassiman JJ; Alman BA
    Oncogene; 1999 Nov; 18(47):6615-20. PubMed ID: 10597266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.
    Miyoshi Y; Iwao K; Nawa G; Yoshikawa H; Ochi T; Nakamura Y
    Oncol Res; 1998; 10(11-12):591-4. PubMed ID: 10367940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
    Lips DJ; Barker N; Clevers H; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.
    Jilong Y; Jian W; Xiaoyan Z; Xiaoqiu L; Xiongzeng Z
    Pathology; 2007 Jun; 39(3):319-25. PubMed ID: 17558858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor).
    Li C; Bapat B; Alman BA
    Am J Pathol; 1998 Sep; 153(3):709-14. PubMed ID: 9736021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
    Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor).
    Ferenc T; Wroński JW; Kopczyński J; Kulig A; Sidor M; Stalińska L; Dziki A; Sygut J
    Pathol Res Pract; 2009; 205(5):311-24. PubMed ID: 19124205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormalities of chromosome 8, APC and beta-catenin genes in aggressive fibromatosis].
    Yang JL; Wang J; Zhou XY; Zhu XZ
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):116-20. PubMed ID: 18646694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
    Friedrich A; Kullmann F
    Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
    Kohler EM; Chandra SH; Behrens J; Schneikert J
    Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
    Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
    J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
    Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
    Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
    Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [From gene to disease; the APC gene and familial adenomatous polyposis coli].
    van der Luijt RB; Tops CM; Vasen HF
    Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2007-9. PubMed ID: 11072519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling.
    Kielman MF; Rindapää M; Gaspar C; van Poppel N; Breukel C; van Leeuwen S; Taketo MM; Roberts S; Smits R; Fodde R
    Nat Genet; 2002 Dec; 32(4):594-605. PubMed ID: 12426568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
    Inukai T; Furuuchi K; Sugita K; Uno K; Ooi A; Sasaki F; Hamada J; Moriuchi T; Nakazawa S
    Oncol Rep; 2004 Jan; 11(1):121-6. PubMed ID: 14654913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APC truncation and increased beta-catenin levels in a human breast cancer cell line.
    Schlosshauer PW; Brown SA; Eisinger K; Yan Q; Guglielminetti ER; Parsons R; Ellenson LH; Kitajewski J
    Carcinogenesis; 2000 Jul; 21(7):1453-6. PubMed ID: 10874025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.
    Aust DE; Terdiman JP; Willenbucher RF; Chew K; Ferrell L; Florendo C; Molinaro-Clark A; Baretton GB; Löhrs U; Waldman FM
    Mod Pathol; 2001 Jan; 14(1):29-39. PubMed ID: 11211307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
    Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
    Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.